Cancer Immunology Project Awards

*This funding scheme is closed and is no longer accepting applications. See our available opportunities here.*

Applications are accepted from:

• Scientists, clinicians or health care workers from UK universities, medical schools, hospitals and some research institutes.
• The lead applicant (PI) must be an immunologist who should not have a demonstrated track record in cancer research.
• Collaborations with cancer researchers/clinicians are strongly encouraged to deliver the project but are not a mandatory requirement.

If you have a demonstrated track record in cancer, or are a group leader at a CRUK core-funded Institute, you are not eligible to apply for this award as the lead PI, but may act as a co-investigator or collaborator.

The aim of the scheme is to build capacity in cancer immunology; therefore, if you already have a demonstrated track record in cancer research, our other opportunities in discovery research may be more suitable for your research.

Scientific remit

Your proposal should address key questions in the immunology of cancer. Applications can be in any area of immunological research, providing the cancer relevance is clearly articulated in the proposal, including any of the following key areas:

• Cellular and molecular immunology: including but not limited to mechanisms of tolerance, the regulation of immune function, the development of memory, the interaction of immune cells with tissues and enhancing the immune system’s ability to detect and destroy cancer.

• Inflammation, allergy, transplantation and autoimmunity: how the basic understanding of relevant mechanisms involved could drive forward our understanding of cancer as well as how sensing of endogenous changes in immune homeostasis, such as tissue damage, impacts on the sensing and development of cancers.

• Immune response to infection: including but not limited to immunity and disease susceptibility/resistance and the development of adverse infections in response to immune therapy or biological drug intervention.

If you are looking for support for the discovery and development of new biotherapeutics or immunomodulatory agents, explore our opportunities in drug discovery and development.